Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Zhan-quan LI"'
Autor:
Quan-Min Jing, Xin Zhao, Ya-Ling Han, Ling-Ling Gao, Yang Zheng, Zhan-Quan Li, Ping Yang, Hong-Liang Cong, Chuan-Yu Gao, Tie-Min Jiang, Hui Li, Jun-Xia Li, Dong-Mei Wang, Geng Wang, Zhan-Chun Cong, Zhong Zhang, Yuan-Yuan Ji
Publikováno v:
Chinese Medical Journal, Vol 133, Iss 8, Pp 899-908 (2020)
Abstract. Background. Treatment of coronary bifurcation lesions remains challenging; a simple strategy has been preferred as of late, but the disadvantage is ostium stenosis or even occlusion of the side branch (SB). Only a few single-center studies
Externí odkaz:
https://doaj.org/article/51026ebac47943fa849d00526b15f97d
Autor:
Zhan-quan, Li, Ming, Zhang, Yuan-zhe, Jing, Wei-wei, Zhang, Ying, Liu, Li-jie, Cui, Long, Yuan, Xian-zhi, Liu, Xian, Yu, Tie-shi, Hu
Publikováno v:
In International Journal of Cardiology 2007 115(1):52-56
Autor:
Wei Wang, Hong-Yun Zang, Zhan-Quan Li, Ping Hou, Xiao-Qun Zheng, Ai-Jie Hou, Zhi-Lin Miao, Hai-Long Lin, Ru-Gang Huang, Fei Xia
Publikováno v:
Journal of Thoracic Disease. 9:54-63
Background This study aims to investigate the effects of recombinant human brain natriuretic peptide (rhBNP) on serum enzyme data, cardiac function parameters and cardiovascular events in patients with acute anterior myocardial infarction (MI). Metho
Autor:
Changyong Zhou, Manqing Wang, Yingxian Sun, Mingxin Liu, Zhan-quan Li, Lanfeng Wang, Zhaoqing Sun, Hui Li, Liang Guo, Dayi Hu, Xingli Liu, Xiaoying Cui, Guizhou Tao, Ying Liu, Wenyue Pang, Hongwei Shan, Lei Yin, Jia Li, Xiaofan Guo
Publikováno v:
International Journal of Cardiology. 172:326-331
Background It is necessary to develop a new thrombolytic agent which can be used by a single bolus at first aid sites to decrease the time to reperfusion in clinical practice. HTUPA, a genetically engineered new thrombolytic with a longer half-life,
Autor:
Zhan Quan Li, Tsung O. Cheng, Yuan Zhe Jin, Li Liu, Wei Wei Zhang, Lin Yang Zhao, Ru Ming Guan, Shu Bin Qiao
Publikováno v:
International Journal of Cardiology. 93:197-202
Background : Percutaneous transluminal septal myocardial ablation (PTSMA) has been introduced as an alternative treatment for hypertrophic obstructive cardiomyopathy (HOCM). We report on the acute, short- and long-term results of our experiences in 1
Publikováno v:
Medicine. 96:e8555
Lipid-lowering therapy with statins reduces the risk of cardiovascular events, but the efficacy of persistent treatment in a real-world setting may vary from regions. Routine lipid-lowering therapy in the region with a high prevalence of cardiovascul
Effect of homocysteine on mitochondrial membrane potential of human umbilical vein endothelial cells
Publikováno v:
Global Journal of Cardiovascular and Cerebrovascular Diseases, Vol 1, Iss 1 (2013)
Objective: To observe the changes of endothelial mitochondrial membrane potential(MMP)by building Hcy-induced endothelial impairment model in cultured human umbilical vein endothelial cells and to analyze the mechanism of Hcy-induced apoptosis.Me
Autor:
Bo, Xu, Run-Lin, Gao, Rui-Yan, Zhang, Hai-Chang, Wang, Zhan-Quan, Li, Yue-Jin, Yang, Chang-Sheng, Ma, Ya-Ling, Han, Alexandra J, Lansky, Yong, Huo, Wei, Li, Martin B, Leon
Publikováno v:
Chinese medical journal. 126(6)
Previous studies indicated that long coronary lesions are one of the key predictors of drug-eluting stent (DES) failure. The purpose of this study was to evaluate the efficacy and the safety of the long length FIREHAWK(®) stent in long coronary arte
Publikováno v:
In vitro cellulardevelopmental biology. Animal. 49(9)
In this report, a slow-growing subpopulation of human umbilical cord mesenchymal stromal cells (MSCs) was identified. These cells were around 5 μm in diameter and their relative gravity was between 1.031 and 1.043 g/ml. In sharp contrast to the pare
Publikováno v:
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi. 33(4)